Amundi’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275M | Buy |
5,780,139
+513,255
| +10% | +$24.4M | 0.1% | 202 |
|
|
2025
Q1 | $305M | Buy |
5,266,884
+127,236
| +2% | +$7.36M | 0.11% | 189 |
|
|
2024
Q4 | $292M | Sell |
5,139,648
-2,655,099
| -34% | -$151M | 0.1% | 193 |
|
|
2024
Q3 | $409M | Sell |
7,794,747
-576,788
| -7% | -$30.3M | 0.15% | 142 |
|
|
2024
Q2 | $335M | Buy |
8,371,535
+2,503,473
| +43% | +$100M | 0.13% | 154 |
|
|
2024
Q1 | $288M | Buy |
5,868,062
+876,155
| +18% | +$43M | 0.12% | 178 |
|
|
2023
Q4 | $256M | Sell |
4,991,907
-1,084,804
| -18% | -$55.6M | 0.12% | 202 |
|
|
2023
Q3 | $343M | Sell |
6,076,711
-93,540
| -2% | -$5.28M | 0.17% | 136 |
|
|
2023
Q2 | $398M | Sell |
6,170,251
-1,596,638
| -21% | -$103M | 0.2% | 119 |
|
|
2023
Q1 | $542M | Sell |
7,766,889
-684,476
| -8% | -$47.8M | 0.29% | 81 |
|
|
2022
Q4 | $608M | Buy |
8,451,365
+1,173,021
| +16% | +$84.4M | 0.33% | 72 |
|
|
2022
Q3 | $520M | Buy |
7,278,344
+1,914,982
| +36% | +$137M | 0.31% | 72 |
|
|
2022
Q2 | $398M | Buy |
5,363,362
+1,195,638
| +29% | +$88.7M | 0.32% | 77 |
|
|
2022
Q1 | $321M | Buy |
4,167,724
+743,321
| +22% | +$57.2M | 0.22% | 117 |
|
|
2021
Q4 | $221M | Sell |
3,424,403
-1,927,571
| -36% | -$125M | 0.14% | 173 |
|
|
2021
Q3 | $317M | Buy |
5,351,974
+48,819
| +0.9% | +$2.89M | 0.22% | 109 |
|
|
2021
Q2 | $354M | Buy |
+5,303,155
| New | +$354M | 0.25% | 92 |
|